Gilman Hill Asset Management LLC Acquires 559 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)
Gilman Hill Asset Management LLC Acquires 559 Shares of Thermo Fisher Scientific Inc. (NYSE:TMO)
Gilman Hill Asset Management LLC boosted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Rating) by 13.4% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 4,744 shares of the medical research company's stock after purchasing an additional 559 shares during the quarter. Gilman Hill Asset Management LLC's holdings in Thermo Fisher Scientific were worth $2,577,000 at the end of the most recent quarter.
根据Gilman Hill Asset Management LLC在最近提交给美国证券交易委员会的13F文件中显示,该公司在第二季度增持了赛默飞世尔(纽约证券交易所代码:TMO-GET评级)的股票13.4%。该公司在本季度额外购买了559股后,持有这家医学研究公司4744股股票。截至最近一个季度末,Gilman Hill Asset Management LLC持有的Thermo Fisher Science价值257.7万美元。
Several other large investors have also recently added to or reduced their stakes in the company. Cadence Bank NA raised its holdings in shares of Thermo Fisher Scientific by 0.3% in the 1st quarter. Cadence Bank NA now owns 7,050 shares of the medical research company's stock worth $4,164,000 after buying an additional 18 shares in the last quarter. S. R. Schill & Associates lifted its holdings in Thermo Fisher Scientific by 5.5% during the fourth quarter. S. R. Schill & Associates now owns 385 shares of the medical research company's stock worth $257,000 after acquiring an additional 20 shares in the last quarter. Wiley BROS. Aintree Capital LLC raised its stake in shares of Thermo Fisher Scientific by 2.5% in the 1st quarter. Wiley BROS. Aintree Capital LLC now owns 833 shares of the medical research company's stock valued at $492,000 after purchasing an additional 20 shares during the period. Bridgewater Advisors Inc. raised its stake in shares of Thermo Fisher Scientific by 1.7% in the 1st quarter. Bridgewater Advisors Inc. now owns 1,229 shares of the medical research company's stock valued at $726,000 after purchasing an additional 20 shares during the period. Finally, Forefront Analytics LLC raised its stake in shares of Thermo Fisher Scientific by 3.9% in the 1st quarter. Forefront Analytics LLC now owns 528 shares of the medical research company's stock valued at $317,000 after purchasing an additional 20 shares during the period. Institutional investors and hedge funds own 86.50% of the company's stock.
其他几家大型投资者最近也增持或减持了该公司的股份。Cadence Bank NA在第一季度增持了Thermo Fisher Science的股票0.3%。Cadence Bank NA现在拥有这家医疗研究公司7050股股票,价值4,164,000美元,上个季度又购买了18股。S.R.Schill&Associates在第四季度将其在Thermo Fisher Science的持股增加了5.5%。S.R.Schill&Associates在上个季度增持了20股后,现在持有这家医学研究公司385股股票,价值25.7万美元。威利兄弟。安特里资本有限责任公司在第一季度增持了Thermo Fisher Science的股份2.5%。威利兄弟。Aintree Capital LLC在此期间又购买了20股,现在拥有833股这家医疗研究公司的股票,价值492,000美元。Bridgewater Advisors Inc.在第一季度增持了Thermo Fisher Science的股份1.7%。Bridgewater Advisors Inc.在此期间又购买了20股,现在拥有1,229股这家医学研究公司的股票,价值72.6万美元。最后,Forefront Analytics LLC在第一季度将其在Thermo Fisher Science的股份增加了3.9%。Forefront Analytics LLC现在拥有这家医疗研究公司528股股票,价值31.7万美元,在此期间又购买了20股。机构投资者和对冲基金持有该公司86.50%的股票。
Analysts Set New Price Targets
分析师设定新的价格目标
A number of research firms recently commented on TMO. Barclays reduced their price target on Thermo Fisher Scientific from $685.00 to $595.00 and set an "overweight" rating for the company in a report on Monday, September 12th. Morgan Stanley boosted their price objective on shares of Thermo Fisher Scientific from $670.00 to $678.00 and gave the company an "overweight" rating in a research report on Friday, July 29th. Credit Suisse Group began coverage on shares of Thermo Fisher Scientific in a report on Wednesday, August 24th. They set a "neutral" rating and a $675.00 price target for the company. Finally, SVB Leerink increased their price objective on Thermo Fisher Scientific from $630.00 to $650.00 and gave the company an "outperform" rating in a report on Friday, July 29th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $656.56.
一些研究公司最近对TMO发表了评论。巴克莱将Thermo Fisher Science的目标价从685.00美元下调至595.00美元,并在12日(周一)的一份报告中对该公司设定了“增持”评级。摩根士丹利在7月29日星期五的一份研究报告中将他们对Thermo Fisher Science的股票目标价从670.00美元上调至678.00美元,并给予该公司“增持”评级。瑞士信贷集团在8月24日星期三的一份报告中开始报道Thermo Fisher Science的股票。他们为该公司设定了“中性”评级和675.00美元的目标价。最后,SVB Leerink将Thermo Fisher Science的目标价从630.00美元上调至650.00美元,并在7月29日(星期五)的一份报告中给出了该公司“跑赢大盘”的评级。一名投资分析师对该股的评级为卖出,两名分析师给予持有评级,七名分析师给予买入评级,一名分析师给予该公司强烈买入评级。根据MarketBeat.com的数据,该公司的普遍评级为“适度买入”,平均目标价为656.56美元。
Insider Buying and Selling at Thermo Fisher Scientific
Thermo Fisher Science的内部买入和卖出
Thermo Fisher Scientific Trading Down 0.4 %
Thermo Fisher Science交易下跌0.4%
Shares of TMO traded down $2.05 during midday trading on Friday, hitting $518.24. The stock had a trading volume of 8,920 shares, compared to its average volume of 1,076,331. Thermo Fisher Scientific Inc. has a 1 year low of $497.83 and a 1 year high of $672.34. The firm has a market cap of $203.04 billion, a PE ratio of 27.69, a price-to-earnings-growth ratio of 1.64 and a beta of 0.85. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.65 and a quick ratio of 1.13. The stock's 50 day moving average is $567.60 and its 200 day moving average is $558.21.
在周五午盘交易中,东京三菱的股价下跌了2.05美元,跌至518.24美元。该股成交量为8920股,而其平均成交量为1,076,331股。Thermo Fisher Science Inc.的股价一年来最低,为497.83美元,一年来最高为672.34美元。该公司市值为2,030.4亿美元,市盈率为27.69倍,市盈率为1.64倍,贝塔系数为0.85。该公司的债务权益比为0.69,流动比率为1.65,速动比率为1.13。该股的50日移动均线切入位在567.60美元,200日移动均线切入位在558.21美元。
Thermo Fisher Scientific (NYSE:TMO – Get Rating) last posted its earnings results on Thursday, July 28th. The medical research company reported $5.51 EPS for the quarter, beating analysts' consensus estimates of $4.92 by $0.59. Thermo Fisher Scientific had a net margin of 17.37% and a return on equity of 24.36%. The business had revenue of $10.97 billion for the quarter, compared to the consensus estimate of $9.95 billion. During the same quarter last year, the firm posted $5.60 EPS. The company's revenue for the quarter was up 18.3% on a year-over-year basis. As a group, analysts forecast that Thermo Fisher Scientific Inc. will post 22.92 EPS for the current fiscal year.
Thermo Fisher Science(纽约证券交易所代码:TMO-GET Rating)最近一次公布收益结果是在7月28日星期四。这家医疗研究公司公布本季度每股收益为5.51美元,比分析师普遍预期的4.92美元高出0.59美元。Thermo Fisher Science的净利润率为17.37%,股本回报率为24.36%。该业务本季度营收为109.7亿美元,而市场普遍预期为99.5亿美元。去年同一季度,该公司公布的每股收益为5.60美元。该公司本季度营收同比增长18.3%。分析师预计,Thermo Fisher Science Inc.本财年每股收益将达到22.92欧元。
Thermo Fisher Scientific Dividend Announcement
Thermo Fisher科学股息公告
The business also recently announced a quarterly dividend, which will be paid on Friday, October 14th. Investors of record on Thursday, September 15th will be paid a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a yield of 0.23%. The ex-dividend date of this dividend is Wednesday, September 14th. Thermo Fisher Scientific's dividend payout ratio (DPR) is presently 6.39%.
该公司最近还宣布了季度股息,将于10月14日(星期五)支付。9月15日(星期四)登记在册的投资者将获得0.30美元的股息。这意味着年化股息为1.20美元,收益率为0.23%。本次股息除息日为9月14日星期三。Thermo Fisher Science的股息支付率(DPR)目前为6.39%。
Thermo Fisher Scientific Profile
Thermo Fisher科学概况
(Get Rating)
(获取评级)
Thermo Fisher Scientific Inc offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
赛默飞世尔在全球范围内提供生命科学解决方案、分析仪器、专业诊断以及实验室产品和服务。该公司的生命科学解决方案部门为制药、生物技术、农业、临床、医疗保健、学术和政府市场提供用于生物和医学研究、发现和生产药物和疫苗的试剂、仪器和消耗品,以及感染和疾病的诊断。
See Also
另请参阅
- Get a free copy of the StockNews.com research report on Thermo Fisher Scientific (TMO)
- Is Costco's Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- What Steelcase's Earnings Say About the Return to the Office?
- 免费获取StockNews.com关于Thermo Fisher Science(TMO)的研究报告
- 好市多盈利后价格疲软是买入的好时机吗?
- 需要关注的2只半导体类股走势逆转
- CrowdStrike是否会从增加每股收益指引中获得提振?
- 小盘股的裁员是楼市的晴雨表吗?
- 斯蒂尔凯斯的收益说明了他重返办公室的原因吗?
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
接受《Thermo Fisher科学日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Thermo Fisher Science和相关公司的最新新闻和分析师评级的每日简要摘要。